Antiseizure medication adherence trajectories in Medicare beneficiaries with newly treated epilepsy.

Samuel W Terman Wesley T KerrZachary A MarcumLu WangJames F Burke

Published in: Epilepsia (2021)

We identified four ASM adherence trajectories in individuals with newly treated epilepsy. Whereas risk factors for early nonadherence such as race or geographic region are nonmodifiable, our work highlighted a modifiable risk factor for early nonadherence: lacking a neurologist. These data may guide future interventions aimed at improving ASM adherence, in terms of both timing and target populations.

Keyphrases

depressive symptoms
electronic health record
physical activity
healthcare
current status
big data
machine learning
metabolic syndrome
genetic diversity
weight loss